Sahm Adrangi in 2009 started the Kerrisdale Capital Management, and he is involved in running its daily activities. Sahm is the company president and the Chief Executive Officer, and recently the company announced a negative on the Proteostasis Therapeutics Inc. According to Kerrisdale the company Proteostasis Therapeutics that deals with investigational of cystic-fibrosis drug the PTI-428 is entirely ineffective and it’s bound to fail within its Phase 3 trials.
Sahm Adrangi states that the short position of Proteostasis Therapeutics Inc and if the prices fall the Kerrisdale is bound to benefit hugely. The Kerrisdale Capital Management started with a low capital of $1 million, and it has propelled and grew enormously increasing its assets base to over $500 million. The company uses unorthodox ways of investing that are also fundamentally-oriented to focusing on the long-term values of its clients and also uses the event-driven unique situation strategies. The company approaches the power of betting on different public companies before publicly listing on the stock exchange by tapping on their annual returns and through the policy Kerrisdale has made over 28% earning on companies yield.
Sahm Adrangi states the company strategies has enabled it to grow the capital and encourage their investors to invest in different public companies before their stocks listing. They use different short positions with the latest being on Proteostasis Therapeutics that received an increase of 100% of its share during their listing helping the early investors like Kerrisdale gain huge yields.
Sahm Adrangi boasts of being learned and attending the most notable university of Yale for his economic degree with high honours. His career started as investment analysts and his keen abilities and unique talent of analysing the stock market saw Sahm Adrangi join the Longacre Funds Company. He managed assets worth $1.2 billion and later he went to Chanin Capital and played a crucial role in equity funds, Chapter 11 bankrupts, companies restructuring among others. Sahm Adrangi has a vast knowledge of credit, company leveraging and debts refinancing making practical to move Kerrisdale Capital to high levels. Sahm has published different articles on matters about investments on New York Times Journal sought-after speaker on the issues pertaining venture strategies.